Gastrointestinal Manifestations Among Patients With COVID19

Completed

• Conditions: Covid19

• Registration Number: NCT04544150
• Lead Sponsor: Assiut University

Brief Summary

many patients with confirmed infection with COVID-19 suffer from different symptoms and signs of gastrointestinal symptoms

Detailed Description

many patients with COVID1-9 infection experienced many intestinal symptoms mainly abdominal pain, vomiting, and diarrhea. This study aimed to assess the frequency of GIT manifestations among patients with COVID-19 and its impact on the outcome

Study Timeline

• Study Start: 2020-06-01
• Status Verified: 2020-09
• Primary Completion: 2020-09-01
• Study Completion: 2020-09-01
• Study First Submitted: 2020-09-08
• Study First Submitted QC: 2020-09-08
• Last Update Submitted: 2020-09-08
• Study First Posted: 2020-09-10
• Last Update Posted: 2020-09-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

• all patients with COVID19

Exclusion Criteria

• patient refusal to participate in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
frequency of GIT symptoms among patients with COVID-19 infection	Baseline	any GIT symptoms in such patients were recorded

Trial Locations

Locations (1)

Ahmed; 🇪🇬 Al Minyā, Alminya, Egypt